National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Published Date: 1/30/2026
Notice
Summary
The National Heart, Lung, and Blood Institute updated its April 9-10, 2026 meeting by adding registration links for anyone who wants to join the open sessions. If you’re interested in sleep disorders research, now you need to sign up ahead of time to attend. This change helps keep things organized and makes sure everyone can join smoothly—no cost changes or timing shifts beyond the registration details.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Registration Now Required to Attend
You can attend the National Heart, Lung, and Blood Institute Sleep Disorders Research Advisory Board open sessions, but you must register in advance. Registration links were added for Day 1 (April 9, 2026, 1:00 p.m. to 5:00 p.m.) and Day 2 (April 10, 2026, 9:30 p.m. to 2:00 p.m.), and the meeting is open to the public with no cost changes.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-01837 — National Institute of Neurological Disorders and Stroke; Notice of Meeting
The National Institute of Neurological Disorders and Stroke is holding a public meeting on March 10, 2026, to talk about new research ideas and review grant applications. Scientists and organizations applying for funding will be affected, as decisions about research support and money will be made. The meeting includes a public session and a private review, with opportunities to send comments ahead of time.
Next: 2026-01839 — Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Revision of Currently Approved Information Collection; Comment Request; Limited Access Death Master File Certification Program Forms
The Department of Commerce is updating forms for the Limited Access Death Master File program, which affects organizations that use this sensitive data. They’re asking for public comments by March 31, 2026, to make sure the forms are clear and not too much work. These changes aim to keep data safe without costing extra time or money for users.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in